long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 16:57 (541 d 03:30 ago) – Posting: # 21798
Views: 2,411

Dear all,

I would appreciate the forum members thoughts on the following situation.

In short:My interpretation of regulatoy guidelines: adding additional fixed effect factors to the factors mentioned in the guidelines is typically considered as not acceptable by regulators.

best regards & looking forward to some ideas to potentially address this situation


Complete thread:

 Admin contact
21,833 posts in 4,568 threads, 1,554 registered users;
online 14 (0 registered, 14 guests [including 5 identified bots]).
Forum time: Friday 19:27 CET (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz